Policy Issues in the Clinical Development and Use of Immunoth... - 9780309442329

National Academies Press

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer TreatmentProceedings of a Workshop\nAuthor(s): National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Kimberly Maxfield, Erin Balogh\nFormat: Paperback\nPublisher: National Academies Press, United States\nImprint: National Academies Press\nISBN-13: 9780309442329, 978-0309442329\nSynopsis\nImmunotherapy is a form of cancer therapy that harnesses the bodya (TM)s immune system to destroy cancer cells. In recent years, immunotherapies have been developed for several cancers, including advanced melanoma, lung cancer, and kidney cancer. In some patients with metastatic cancers who have not responded well to other treatments, immunotherapy treatment has resulted in complete and durable responses. Given these promising findings, it is hoped that continued immunotherapy research and devel.